Skip to main content
. 2023 Sep 8;11:61. doi: 10.1186/s40635-023-00543-1

Table 2.

Descriptive perioperative data

Overall No complications Complications p-value
n 29 22 7
Norepinephrine, highest rate (µg kg−1 min−1) 0.10 [0.10, 0.20] 0.10 [0.09, 0.14] 0.28 [0.17, 0.30] 0.003
Norepinephrine, cumulative (µg) 1530 [1001, 1922] 1466 [863, 1736] 1922 [1296, 2957] 0.149
Crystalloids (ml) 3000 [2500, 3500] 3000 [2500, 3000] 3000 [2750, 3500] 0.360
Colloids (ml) 1000 [1000, 1000] 1000 [1000, 1000] 1000 [1000, 1250] 0.374
FFP (IE) 1320 [660, 2420] 1320 [660, 2145] 2248 [1320, 2530] 0.124
RBC concentrate (IE) 0 [0, 310] 0 [0, 0] 310 [0, 930] 0.076
Urine output (ml) 660 [275, 800] 690 [470, 1110] 275 [220, 425] 0.036
Blood loss (ml) 500 [300, 1000] 500 [300, 938] 800 [700, 2000] 0.091
Duration of surgery (h) 4.4 [4.0, 5.0] 4.7 [4.0, 5.1] 4.1 [3.6, 4.6] 0.251
Duration of anaesthesia (h) 6.1 [5.8, 6.8] 6.2 [5.8, 6.8] 6.0 [5.6, 6.1] 0.372
Length of stay in PACU or ICU (h) 22.0 [19.6, 46.6] 21.9 [7.7, 38.8] 43.0 [21.5, 122.4] 0.217
Length of stay in hospital (d) 11.7 [11.5, 17.6] 11.6 [10.7, 14.4] 24.7 [18.1, 45.2] 0.002

Data are shown as median [Q25, Q75]. p-values were calculated with the Wilcoxon–Mann–Whitney rank-sum test. FFP fresh frozen plasma, ICU intensive care unit, PACU postanaesthesia care unit; RBC, red blood cell